Common Antidepressants Could Have an Unexpected Role in Cancer Survival
A study suggests that people with cancer who take common antidepressants called SSRIs may have a lower risk of dying within two years compared to those taking other mental health medications. The research looked at patients receiving immunotherapy and found a link between SSRI use and better survival rates, though it does not prove cause and effect. The findings highlight a potential new angle in cancer treatment and mental health care.
Researchers found that cancer patients taking SSRIs had lower death rates over two years compared to those taking benzodiazepines, suggesting a possible connection between these antidepressants and improved cancer outcomes.
The findings could lead to new approaches in combining mental health treatments with cancer care, offering hope for better patient outcomes and more personalized treatment strategies.
The study shows how understanding the body's complex systems can lead to unexpected benefits, emphasizing the value of exploring connections between different areas of health care.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.